Industry

Recursion Pharmaceuticals

Clinical-stage biotechnology company using AI for drug discovery

Location: Salt Lake City, UT
Website
3 models(1 Single-cell, 1 Protein, 1 Imaging)

Models (3)

TxFM

Recursion Pharmaceuticals

Released May 31, 2026

2

A self-supervised masked autoencoder for RNA-seq count data, pretrained on 1.4M public samples to learn transferable transcriptomic representations without per-dataset re-training.

Single-cell

Boltz-2

MIT CSAIL / Recursion Pharmaceuticals

Released June 1, 2025

3754K

Open model that jointly predicts biomolecular structure and small-molecule binding affinity, approaching FEP+ accuracy in seconds on a single GPU.

Protein

OpenPhenom-S/16

Recursion Pharmaceuticals

Released November 12, 2024

803.5K77

Channel-agnostic Vision Transformer trained on 3M+ Cell Painting images via masked autoencoder, producing 384-dimensional morphological embeddings for zero-shot phenotypic analysis.

Imaging